Literature DB >> 22745590

BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.

Keisuke Taniuchi1, Kunihiko Yokotani, Toshiji Saibara.   

Abstract

We report that Binder of Arl Two (BART) plays a role in inhibiting cell invasion by regulating the activity of the Rho small guanosine triphosphatase protein Rac1 in pancreatic cancer cells. BART was originally identified as a binding partner of ADP-ribosylation factor-like 2, a small G protein implicated as a regulator of microtubule dynamics and folding. BART interacts with active forms of Rac1, and the BART-Rac1 complex localizes at the leading edges of migrating cancer cells. Suppression of BART increases active Rac1, thereby increasing cell invasion. Treatment of pancreatic cancer cells in which BART is stably knocked down with a Rac1 inhibitor decreases invasiveness. Thus, BART-dependent inhibition of cell invasion is likely associated with decreased active Rac1. Suppression of BART induces membrane ruffling and lamellipodial protrusion and increases peripheral actin structures in membrane ruffles at the edges of lamellipodia. The Rac1 inhibitor inhibits the lamellipodia formation that is stimulated by suppression of BART. Our results imply that BART regulates actin-cytoskeleton rearrangements at membrane ruffles through modulation of the activity of Rac1, which, in turn, inhibits pancreatic cancer cell invasion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22745590      PMCID: PMC3384431          DOI: 10.1593/neo.12352

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  41 in total

Review 1.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Interaction of protein kinase C isozymes with Rho GTPases.

Authors:  S J Slater; J L Seiz; B A Stagliano; C D Stubbs
Journal:  Biochemistry       Date:  2001-04-10       Impact factor: 3.162

3.  Feedback interactions between cell-cell adherens junctions and cytoskeletal dynamics in newt lung epithelial cells.

Authors:  C M Waterman-Storer; W C Salmon; E D Salmon
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

4.  E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts.

Authors:  Eva M Kovacs; Radiya G Ali; Ailsa J McCormack; Alpha S Yap
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

5.  Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.

Authors:  S Aznar; P F Valerón; S V del Rincon; L F Pérez; R Perona; J C Lacal
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

6.  Osmotic stress activates Rac and Cdc42 in neutrophils: role in hypertonicity-induced actin polymerization.

Authors:  Alison Lewis; Caterina Di Ciano; Ori D Rotstein; András Kapus
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

Review 7.  Putting a new twist on actin: ADF/cofilins modulate actin dynamics.

Authors:  J R Bamburg; A McGough; S Ono
Journal:  Trends Cell Biol       Date:  1999-09       Impact factor: 20.808

8.  Osmotic stress-induced remodeling of the cortical cytoskeleton.

Authors:  Caterina Di Ciano; Zilin Nie; Katalin Szászi; Alison Lewis; Takehito Uruno; Xi Zhan; Ori D Rotstein; Alan Mak; András Kapus
Journal:  Am J Physiol Cell Physiol       Date:  2002-09       Impact factor: 4.249

Review 9.  Surgical management of pancreatic cancer.

Authors:  Steven A Ahrendt; Henry A Pitt
Journal:  Oncology (Williston Park)       Date:  2002-06       Impact factor: 2.990

Review 10.  Rho GTPases and cell migration.

Authors:  A J Ridley
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  13 in total

Review 1.  Targeting Rac and Cdc42 GTPases in Cancer.

Authors:  María Del Mar Maldonado; Suranganie Dharmawardhane
Journal:  Cancer Res       Date:  2018-06-01       Impact factor: 12.701

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.

Authors:  Makiko Tsuboi; Keisuke Taniuchi; Takahiro Shimizu; Motoaki Saito; Toshiji Saibara
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.157

4.  BCL7B, a predictor of poor prognosis of pancreatic cancers, promotes cell motility and invasion by influencing CREB signaling.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Seiji Naganuma; Ken Dabanaka; Kazuhiro Hanazaki; Toshiji Saibara
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

5.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

6.  Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Kazuhiro Hanazaki; Shinji Iwasaki; Kenjiro Tanaka; Takahiro Shimizu; Motoaki Saito; Toshiji Saibara
Journal:  Pancreas       Date:  2015-03       Impact factor: 3.327

7.  CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.

Authors:  Aki Tanouchi; Keisuke Taniuchi; Mutsuo Furihata; Seiji Naganuma; Ken Dabanaka; Masashi Kimura; Ryohei Watanabe; Takuhiro Kohsaki; Takahiro Shimizu; Motoaki Saito; Kazuhiro Hanazaki; Toshiji Saibara
Journal:  J Exp Clin Cancer Res       Date:  2016-12-05

8.  KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Toshiji Saibara
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

9.  IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Kazuhiro Hanazaki; Motoaki Saito; Toshiji Saibara
Journal:  Oncotarget       Date:  2014-08-30

10.  Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.

Authors:  Keisuke Taniuchi; Mutsuo Furihata; Seiji Naganuma; Ken Dabanaka; Kazuhiro Hanazaki; Toshiji Saibara
Journal:  Cancer Sci       Date:  2016-09-02       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.